Asuragen Raises $5.0M

Austin-based molecular diagnostics firm Asuragen has raised $5.0M, on its way to a $10.0M funding, according to a regulatory filing by the firm this week. Asuragen is a spinout of Ambion, the molecular biology reagent firm founded by former University of Texas professor Matt Winkler. The firm spun out of Ambion in 2006, after Ambion's research product division was sold to Applied Biosystems. No details on the new funding have been announced by the company. More information »